STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM
26 juin 2024 10h00 HE
|
Monteverde & Associates PC
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022...
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM
21 juin 2024 11h02 HE
|
Monteverde & Associates PC
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the...
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – SQSP, RPHM, SBOW, NX
29 mai 2024 13h29 HE
|
Monteverde & Associates PC
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the...
Kuehn Law Encourages SQSP, HRT, RPHM, and ALE Investors to Contact Law Firm
14 mai 2024 15h52 HE
|
KUEHN LAW, PLLC
Kuehn Law Encourages SQSP, HRT, RPHM, and ALE Investors to Contact Law Firm
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
13 mai 2024 07h35 HE
|
Reneo Pharmaceuticals, Inc.; OnKure, Inc
Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology Combined company is expected to have...
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
07 mai 2024 07h35 HE
|
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results